Operative Onkologie: Mögliche Wege zur Finanzierung komplexer onkologischer Therapieverfahren

Henne‐Bruns, Doris; Vogel, Ilka; Marxen, J.; Papachrysanthou, A.; Förster, Jürgen; Rüschmann, Hans-Heinrich; Buschmann, P.; Baxmann, M.; Kremer, Bernd

doi:10.1007/978-3-642-60881-0_63

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Unclassified

Year Published

2000

Publication Types

Select...

Article1

Relationship

Self Cite1

Independent0

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Aus der detaillierten Analyse aller Kostenarten und Kostenstellen ergaben sich dann die Gesamtkosten je Fallgruppe (Tabelle 2). Zusa Ètzlich wurden die Kosten fu Èr eine psychoonkologische Betreuung sowie eine Tumoreinzelzelldiagnostik kalkuliert[4]. Eine Ûbersicht u Èber die fu Èr jeden Pfad ermittelten Positionen sowie die als Berechnungsgrundlage dienende Bezugsbasis zeigt Tabelle 3.…”

unclassified

Diagnose-orientierte Diagnostik, Therapie und Kostenerstattung in der operativen Onkologie - Ein Modellversuch -

Henne‐Bruns¹,

Löhnert²,

Marxen³

et al. 2000

Zentralbl Chir

Self Cite

View full text Add to dashboard Cite

In 1996 the project "operative oncology" was initiated by the Department of Surgery University of Kiel in order to guarantee a solid and longterm financing of surgical oncological interventions with a high quality standard. First step was to determine the detailed costs of the diagnostic and different surgical procedures in order to calculate flat rates per case. Covered by these comprehensive prices per case are also the psychooncological support, prospective evaluation of quality of life and molecular-oncological diagnostics (determination of micrometastasis). The development of project was primarily financed by the AOK health insurance company of Schleswig-Holstein. It was calculated by the GSbG and is supported since April, 1st, 1998 by all health insurance companies of the region.

show abstract

unclassified